Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Human Immunology|May 14, 2011
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control studySara Galluzzo, Giuseppe Patti, Giordano Dicuonzo, et al.
International Immunopharmacology|December 14, 2004
Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: reviewNicole Suciu-Foca, John S Manavalan, Luigi Scotto, et al.
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
Targeting EGFR in bilio-pancreatic and liver carcinomaMaria Elisabetta Fratto, Daniele Santini, Bruno Vincenzi, et al.
Arthritis and Rheumatism|June 4, 2005
Thrombosis in systemic lupus erythematosus: congenital and acquired risk factorsAntonella Afeltra, Marta Vadacca, Laura Conti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patientsDaniele Santini, Bruno Vincenzi, Sara Galluzzo, et al.
Oncology Reports|October 25, 2008
Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysisBruno Vincenzi, Giuseppe Patti, Sara Galluzzo, et al.
Human Immunology|November 24, 2004
Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cellsLuigi Scotto, Afzal Jamal Naiyer, Sara Galluzzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcomeBruno Vincenzi, Daniele Santini, Sara Galluzzo, et al.
Frontiers in Medicine|July 25, 2025
New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug developmentRoberto De Lisa, Fernando de Andres-Trelles, Ralph Bax, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2008
In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patientsDaniele Santini, Federico Martini, Maria Elisabetta Fratto, et al.
Pageof 4